Skip to content

Author

Carolyn S. P. Lam

We have 6 of 58 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Nov 2026

Controversy: Atrial fibrillation ablation should be performed in patients with HFpEF.

The role of atrial fibrillation (AF) ablation in the management of heart failure with preserved ejection fraction (HFpEF) remains an under investigated issue with no robust clinical trials data. This controversy reviews the evidence for and against AF ablation in this complex condition from two different perspectives r...

L. di Biase, Carolyn S. P. Lam, Feng-Wei Zou et al. · 0 citations
Sep 2026

Myeloperoxidase inhibition with mitiperstat in heart failure with preserved or mildly reduced ejection fraction: a randomized phase 2b trial

Treatment with mitiperstat, intended to target the neutrophil–MPO inflammatory pathway, did not improve symptoms or exercise function in individuals with heart failure with preserved or mildly reduced ejection fraction.

Lars H. Lund, Carolyn S. P. Lam, P. E. Pizzato et al. · 1 citation
Open access Aug 2026

HFpEF-ABA Score and Finerenone in Patients With Heart Failure and Mildly Reduced or Preserved Ejection Fraction: Insights From the FINEARTS-HF Trial.

BACKGROUND The HFpEF-ABA score is a simple diagnostic tool developed to estimate the probability of heart failure with preserved ejection fraction (HFpEF) using age, body mass index, and history of atrial fibrillation. OBJECTIVES This study aims to evaluate the HFpEF-ABA score in patients with confirmed heart failure...

R. Ono, K. Docherty, A. Henderson et al. · 0 citations
Open access Aug 2026

Targeted Assessment in High-Risk Patients With Diabetes to Identify Undiagnosed Heart Failure (TARTAN-HF).

BACKGROUND Heart failure (HF) is a common cardiovascular complication of diabetes. Early identification of unrecognized HF enables initiation of disease-modifying therapies. International diabetes and HF clinical practice guidelines are inconsistent with respect to recommendations for screening for HF in people with di...

D. Taylor-Sweet, M. Petrie, Gemma Mckinley et al. · 1 citation
Open access Sep 2026

Persistent C-reactive protein elevation and incident heart failure in adults at increased cardiovascular risk: A multinational electronic health record study.

In this selected cohort of adults at increased CV risk, persistent CRP elevation was associated with higher risk of incident HF and all-cause mortality and may suggest the prognostic relevance of elevated CRP and warrant further study of inflammation in HF development.

M. Busti, L. Monzo, T. Rastogi et al. · 1 citation
Open access Aug 2026

The impact and evolution of environmental/occupational, behavioural, and metabolic risk factors on CVD burdens in the Asia–Pacific region from 1990 to 2023: a secondary analysis of the Global Burden of Disease Study 2023

The improvements in cardiovascular risk factor exposure in the Asia–Pacific have been offset by population growth and ageing, and the metabolic-centric pattern in risk factors demands for strategies in tackling the region's high priority metabolic risk factor targets.

Nicholas W. S. Chew, Yi-Ming Chen, F. Cader et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.